Advanced Life Sciences Announces Appointment of Pharmaceutical Executive to Board of Directors

Woodridge, Ill, August 20, 2001 - Advanced Life Sciences, Inc. announced today the appointment of Terry W. Osborn Ph.D., MBA, to its Board of Directors. Dr. Osborn is a pharmaceutical executive with bottom-line and results oriented pharmaceutical experience.

"We are very pleased that Dr. Osborn has joined our Board of Directors," said Dr. Sharon W. Ayd, Chief Operating Officer of Advanced Life Sciences. "We expect him to help initially by working with us to optimize our near-term strategic direction, focusing on issues most relevant to our fund raising needs. His longer-term focus will be on technology and business development."

Dr. Osborn was previously Chief Executive Officer of Pharmaceutical Development Center, based in Charleston, S.C., and was Founder, President, and Chief Executive Officer of Health Advance Institute. His corporate experience includes management, planning and marketing positions with Nichols Institute, IVAC and American McGaw. Dr. Osborn received his Ph.D. in Biochemistry from the University of California at Riverside and his MBA from Pepperdine University.

Advanced Life Sciences, Inc., based in Woodridge, Illinois ( is a privately held, early-stage pharmaceutical technology development company that discovers and develops therapeutic compounds to fight infection, inflammation and cancer. The company bridges the gap between academic discoveries and pharmaceutical commercialization and focuses on conditions that have significant unmet medical needs in medium sized markets

# # #